TASCOM Co.,Ltd. (XKON:336040)

Market Cap	19.37B
Revenue (ttm)	5.53B
Net Income (ttm)	-1.74B
Shares Out	4.68M
EPS (ttm)	-824.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	106
Average Volume	44
Open	3,700.00
Previous Close	4,000.00
Day's Range	3,700.00 - 4,135.00
52-Week Range	2,975.00 - 8,400.00
Beta	0.12
RSI	45.73
Earnings Date	n/a

About TASCOM

TASCOM Co.,Ltd. manufactures and distributes diabetic supplies in South Korea. Its products include blood glucose measurement system-acuraview, BD ultra fine PRO pen needle, syringes-BD ultrafine syringes, Ido sharp container, and Ido safety lancet. The company was formerly known as YIDOBIO Inc. and changed its name to TASCOM Co.,Ltd. in September 2021. TASCOM Co.,Ltd. was founded in 2014 and is headquartered in Anyang-Si, South Korea.

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2014
• Country: South Korea
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 336040

Financial Performance

In 2019, TASCOM's revenue was 9.10 billion, an increase of 64.42% compared to the previous year's 5.53 billion. Losses were -1.97 billion, 13.1% more than in 2018.